For aus clinical labs to adopt the technology proves its timely and cost efficient over traditional methods. STI kits to receive TGA approval in coming months will be another revenue avenue. I think there Is big money for GSS with the STI kits once they become commercially available.
If it was old expensive tech then Aus Clinical Labs would not have adopted this method.
Results in 4 hours. Higher accuracy over traditional methods.
Might be old tech but so is Nearmap technology apparently (WW2 i read)
https://www.adelaidenow.com.au/busi...t/news-story/10c5f2e339b1d53eb77975f830e41b90
Ann: Update to major customer contract announcement, page-9
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
67.5¢ |
Change
-0.015(2.17%) |
Mkt cap ! $155.4M | |||
| Open | High | Low | Value | Volume |
| 68.5¢ | 68.5¢ | 67.5¢ | $8.27K | 12.21K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34322 | 67.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 68.5¢ | 7757 | 1 |
View Market Depth
| Last trade - 13.57pm 29/11/2024 (20 minute delay) ? |
| GSS (ASX) Chart |
